Solid Biosciences Inc. SLDB Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s stock-based comp?
- Solid Biosciences Inc. (SLDB) reported stock-based comp of $5.15M in Q1 2026.
- How has Solid Biosciences Inc.'s stock-based comp changed year-over-year?
- Solid Biosciences Inc.'s stock-based comp increased by 54.2% year-over-year, from $3.34M to $5.15M.
- What is the long-term trend for Solid Biosciences Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s stock-based comp has grown at a 6.0% compound annual growth rate (CAGR), from $13.37M to $16.91M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.